Karen E. Duffy

1.2k total citations
24 papers, 983 citations indexed

About

Karen E. Duffy is a scholar working on Immunology, Epidemiology and Molecular Biology. According to data from OpenAlex, Karen E. Duffy has authored 24 papers receiving a total of 983 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 7 papers in Epidemiology and 5 papers in Molecular Biology. Recurrent topics in Karen E. Duffy's work include Immune Response and Inflammation (10 papers), IL-33, ST2, and ILC Pathways (5 papers) and Asthma and respiratory diseases (5 papers). Karen E. Duffy is often cited by papers focused on Immune Response and Inflammation (10 papers), IL-33, ST2, and ILC Pathways (5 papers) and Asthma and respiratory diseases (5 papers). Karen E. Duffy collaborates with scholars based in United States, United Kingdom and Belgium. Karen E. Duffy's co-authors include Robert T. Sarisky, Sebastian Arangundy‐Franklin, Philipp Holliger, Roberta J. Lamb, M. Lamine Mbow, C. T. Ranjith-Kumar, C. Cheng Kao, Jin Xiong, Mark Cunningham and Jingchuan Sun and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and PLoS ONE.

In The Last Decade

Karen E. Duffy

24 papers receiving 967 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karen E. Duffy United States 17 533 288 236 97 76 24 983
Kihyuck Kwak United States 17 606 1.1× 290 1.0× 432 1.8× 58 0.6× 53 0.7× 33 1.1k
Mathieu Houde Canada 16 772 1.4× 591 2.1× 325 1.4× 77 0.8× 63 0.8× 18 1.6k
Paola Del Porto Italy 24 500 0.9× 400 1.4× 510 2.2× 75 0.8× 46 0.6× 53 1.5k
José Carlos Santos Switzerland 13 547 1.0× 1.1k 3.8× 171 0.7× 84 0.9× 69 0.9× 15 1.5k
Michael P. Rudolf Switzerland 17 451 0.8× 628 2.2× 427 1.8× 44 0.5× 65 0.9× 33 1.4k
Aoi Akitsu Japan 9 882 1.7× 240 0.8× 115 0.5× 69 0.7× 98 1.3× 16 1.2k
Saeed Shafti‐Keramat Austria 14 253 0.5× 174 0.6× 431 1.8× 49 0.5× 28 0.4× 22 789
Rachel J. Lundie Australia 17 1.1k 2.0× 517 1.8× 154 0.7× 63 0.6× 137 1.8× 24 2.0k
Heinz Hoschützky Germany 20 258 0.5× 537 1.9× 102 0.4× 55 0.6× 61 0.8× 24 1.2k
Allison W. Roberts United States 8 340 0.6× 276 1.0× 109 0.5× 58 0.6× 44 0.6× 11 699

Countries citing papers authored by Karen E. Duffy

Since Specialization
Citations

This map shows the geographic impact of Karen E. Duffy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen E. Duffy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen E. Duffy more than expected).

Fields of papers citing papers by Karen E. Duffy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen E. Duffy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen E. Duffy. The network helps show where Karen E. Duffy may publish in the future.

Co-authorship network of co-authors of Karen E. Duffy

This figure shows the co-authorship network connecting the top 25 collaborators of Karen E. Duffy. A scholar is included among the top collaborators of Karen E. Duffy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karen E. Duffy. Karen E. Duffy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nnane, Ivo, Bart Frederick, Zhenling Yao, et al.. (2020). The first‐in‐human study of CNTO 7160, an anti‐interleukin‐33 receptor monoclonal antibody, in healthy subjects and patients with asthma or atopic dermatitis. British Journal of Clinical Pharmacology. 86(12). 2507–2518. 34 indexed citations
2.
Duffy, Karen E., Sebastian Arangundy‐Franklin, & Philipp Holliger. (2020). Modified nucleic acids: replication, evolution, and next-generation therapeutics. BMC Biology. 18(1). 112–112. 104 indexed citations
3.
Sidney, John, Stéphane Bécart, Mimi Zhou, et al.. (2017). Citrullination only infrequently impacts peptide binding to HLA class II MHC. PLoS ONE. 12(5). e0177140–e0177140. 38 indexed citations
4.
Lü, Jin, Sheng‐Jiun Wu, Eilyn R. Lacy, et al.. (2016). Monoclonal antibodies targeting ST2L Domain 1 or Domain 3 differentially modulate IL-33-induced cytokine release by human mast cell and basophilic cell lines. Molecular Immunology. 75. 178–187. 6 indexed citations
5.
Luo, Jinquan, Galina Obmolova, T. Malia, et al.. (2012). Lateral Clustering of TLR3:dsRNA Signaling Units Revealed by TLR3ecd:3Fabs Quaternary Structure. Journal of Molecular Biology. 421(1). 112–124. 42 indexed citations
6.
Wu, Linda, Lani R. San Mateo, Karen E. Duffy, et al.. (2012). Loss of toll-like receptor 3 function improves glucose tolerance and reduces liver steatosis in obese mice. Metabolism. 61(11). 1633–1645. 34 indexed citations
7.
Duffy, Karen E., et al.. (2011). Generation and Characterization of Rat Anti-mouse ST2L Monoclonal Antibodies. Hybridoma. 30(2). 153–162. 5 indexed citations
8.
Shibata, Takehiko, Karen E. Duffy, Ana Paula Moreira, et al.. (2011). Targeting ST2L Potentiates CpG-Mediated Therapeutic Effects in a Chronic Fungal Asthma Model. American Journal Of Pathology. 179(1). 104–115. 31 indexed citations
9.
Duffy, Karen E., Roberta J. Lamb, Lani R. San Mateo, et al.. (2010). Novel antagonist antibody to TLR3 blocks poly(I:C)-induced inflammation in vivo and in vitro. Cellular Immunology. 267(1). 9–16. 16 indexed citations
10.
Joshi, Amrita, Sameer R. Oak, Adam J. Hartigan, et al.. (2010). Interleukin-33 contributes to both M1 and M2 chemokine marker expression in human macrophages. BMC Immunology. 11(1). 52–52. 104 indexed citations
11.
Fang, Teng, et al.. (2009). Toll-like receptor 3 is involved in airway epithelial cell response to nontypeable Haemophilus influenzae. Cellular Immunology. 260(2). 98–104. 15 indexed citations
12.
Ranjith-Kumar, C. T., Karen E. Duffy, Jarrat Jordan, et al.. (2008). Single-Stranded Oligonucleotides Can Inhibit Cytokine Production Induced by Human Toll-Like Receptor 3. Molecular and Cellular Biology. 28(14). 4507–4519. 32 indexed citations
13.
Lamb, Roberta J., Renold J. Capocasale, Karen E. Duffy, Robert T. Sarisky, & M. Lamine Mbow. (2007). Identification and Characterization of Novel Bone Marrow Myeloid DEC205+Gr-1+ Cell Subsets That Differentially Express Chemokine and TLRs. The Journal of Immunology. 178(12). 7833–7839. 8 indexed citations
14.
Ranjith-Kumar, C. T., William R. Miller, Jin Xiong, et al.. (2007). Biochemical and Functional Analyses of the Human Toll-like Receptor 3 Ectodomain. Journal of Biological Chemistry. 282(10). 7668–7678. 51 indexed citations
15.
Ranjith-Kumar, C. T., William R. Miller, Jingchuan Sun, et al.. (2007). Effects of Single Nucleotide Polymorphisms on Toll-like Receptor 3 Activity and Expression in Cultured Cells. Journal of Biological Chemistry. 282(24). 17696–17705. 117 indexed citations
16.
Duffy, Karen E., Roberta J. Lamb, Lani R. San Mateo, et al.. (2007). Down modulation of human TLR3 function by a monoclonal antibody. Cellular Immunology. 248(2). 103–114. 22 indexed citations
17.
Sun, Jingchuan, Karen E. Duffy, C. T. Ranjith-Kumar, et al.. (2006). Structural and Functional Analyses of the Human Toll-like Receptor 3. Journal of Biological Chemistry. 281(16). 11144–11151. 106 indexed citations
18.
Sarisky, Robert T., T. H. Bacon, Ron Boon, et al.. (2003). Profiling penciclovir susceptibility and prevalence of resistance of herpes simplex virus isolates across eleven clinical trials. Archives of Virology. 148(9). 1757–1769. 35 indexed citations
19.
Duffy, Karen E., Matthew R. Quail, Tammy Nguyen, et al.. (2002). Assessing the contribution of the herpes simplex virus DNA polymerase to spontaneous mutations. BMC Infectious Diseases. 2(1). 7–7. 17 indexed citations
20.
Sarisky, Robert T., Tammy Nguyen, Robert J. Wittrock, et al.. (2001). Biochemical Characterization of a Virus Isolate, Recovered from a Patient with Herpes Keratitis, That Was Clinically Resistant to Acyclovir. Clinical Infectious Diseases. 33(12). 2034–2039. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kihyuck Kwak Breakdown of academic impact, for papers by Mathieu Houde Breakdown of academic impact, for papers by Paola Del Porto Breakdown of academic impact, for papers by José Carlos Santos Breakdown of academic impact, for papers by Michael P. Rudolf Breakdown of academic impact, for papers by Aoi Akitsu Breakdown of academic impact, for papers by Saeed Shafti‐Keramat Breakdown of academic impact, for papers by Rachel J. Lundie Breakdown of academic impact, for papers by Heinz Hoschützky Breakdown of academic impact, for papers by Allison W. Roberts
Rankless by CCL
2026